SCHEMBL28544798

SCHEMBL28544798

O=C(O)N(Cc1ccccc1)[C@H]1CC[C@@H](F)C1

nearest known ligand 0.47

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
AGER Q15109 3/20 0.47
MTNR1A P48039 1/20 0.47
CTSD P07339 1/20 0.46
CHRM2 P08172 1/20 0.44
CHRM3 P20309 1/20 0.44
OPRM1 P35372 6/20 0.43
MEN1 O00255 1/20 0.43
KMT2A Q03164 1/20 0.43
HSD17B10 Q99714 1/20 0.42
DCUN1D1 Q96GG9 1/20 0.41
LMNA P02545 2/20 0.40
CCR5 P51681 1/20 0.40
ALDH1A1 P00352 1/20 0.40
TMEM97 Q5BJF2 1/20 0.39
DPP4 P27487 1/20 0.39
DPP9 Q86TI2 1/20 0.39
DPP7 Q9UHL4 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28911006 1.00 AGER (0.47) AGERMTNR1ACTSDCHRM2CHRM3
SCHEMBL3370759 0.85 AGER (0.55) AGERMTNR1ACTSDCHRM2CHRM3
SCHEMBL5436734 0.83 AGER (0.55) AGERMTNR1ACTSDCHRM2CHRM3
SCHEMBL5431901 0.83 AGER (0.55) AGERMTNR1ACTSDCHRM2CHRM3
SCHEMBL1700010 0.81 MC4R (0.49) AGERMTNR1ACTSDCHRM2CHRM3
SCHEMBL17506917 0.81 MC4R (0.49) AGERMTNR1ACTSDCHRM2CHRM3
SCHEMBL736913 0.79 AGER (0.50) AGERMTNR1ACTSDCHRM2CHRM3
SCHEMBL736914 0.79 AGER (0.50) AGERMTNR1ACTSDCHRM2CHRM3
SCHEMBL17157336 0.78 AGER (0.50) AGERMTNR1ACTSDCHRM2CHRM3
SCHEMBL17157513 0.78 AGER (0.50) AGERMTNR1ACTSDCHRM2CHRM3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-108137586-B Novel imidazo [4,5-c ] quinoline and imidazo [4,5-c ] [1,5] naphthyridine derivatives as LRRK2 inhibitors 辉瑞大药厂 2021-04-13 CN disclosed